PH278x: Human Health and Global Environmental Change "Start on May/15/2013

ABOUT PH278X

 One of the greatest challenges of our time is to address global environmental changes, such  as climate change and biodiversity loss, that may harm the health of billions of people worldwide. This class will examine these changes, their causes, as well as their health consequences, and engage students in thinking about their solutions. Those who earn a passing grade will get a certificate of mastery from HarvardX.

COURSE INSTRUCTORS

Aaron Bernstein

Aaron Bernstein, M.D., M.P.H., is the Associate Director of the Center for Health and the Global Environment at the Harvard School of Public Health and a pediatric hospitalist at Boston Children's Hospital. Dr. Bernstein’s work examines the human health effects of global environmental changes, such as climate change and the loss of biodiversity, with the aim of promoting a deeper understanding of these subjects among students, educators, policy makers, and the public.

Jack Spengler

John D. Spengler is the Director of the Center for Health and the Global Environment at the Harvard School of Public Health as well as the Akira Yamaguchi Professor of Environmental Health and Human Habitation. He has conducted research in the areas of personal monitoring, air pollution health effects, aerosol characterization, indoor air pollution and air pollution meteorology. In addition to his academic and research activities, Professor Spengler has been active in professional education workshops, distance learning and short courses. He also serves as an advisor to several global organizations, including the World Health Organization.

1. Course Number
   PH278x
2. Classes Start
   May 15, 2013

Register For  PH278x: Human Health and Global Environmental Change

Posted by Editorial Team on 12:42 PM in Edx, HarvardX, Medicine, Science

UT.4.01x: Take Your Medicine - The Impact of Drug Development

ABOUT TAKE YOUR MEDICINE - THE IMPACT OF DRUG DEVELOPMENT

Everyone gets sick. Thanks to medical innovations in the past 50 years, many diseases and conditions have been either mitigated or even cured through medicine. How does a research innovation turn into a therapeutic medicine that health care providers prescribe to patients? This course explores the process, challenges and issues in developing pharmaceutical products. Drug development is a dynamic field where innovation and entrepreneurship are necessary to keep up with health care expectations, strict regulations and tightening development budgets. An overview of drug development, approval, and consumer issues will be presented and discussed in the context of research practices, science, marketing, public welfare and business. Participants from all backgrounds and interest, including scientists, healthcare professionals, entrepreneurs and the general public, are encouraged to participate.

PREREQUISITES

There are no prerequisites for this course. This course is designed to allow participation by everyone, including the general population and scholars, without prior knowledge.

COURSE INSTRUCTORS

Dr. Janet Walkow

Dr. Janet Walkow is the Executive Director and Chief Technology Officer of the Drug Dynamics Institute (DDI). She joined the faculty of the University of Texas in 2008, building on a successful career in the pharmaceutical industry, where she led efforts ranging from R&D product development to Corporate Strategy. The DDI brings together scientists and investigators to work on novel solutions for disease and healthcare issues, fostering collaborations and developing ways to eliminate drug development. She is passionate about the need for scientists and the general public to understand how medical therapies are developed. A leader in efforts to empower women, Janet is co-founder of the Leading Women Project, empowering women of all ages and professions learn to lead themselves and others.

Dr. Alan Watts

As Assistant Director of the Drug Dynamics Institute (DDI), Alan works with development-focused pharmaceutical researchers in academia and industry to advance drug products through the preclinical stage. Alan also oversees the UTech Dorm Room, a wet lab incubator space, located within the College of Pharmacy. With academic and industry experience in drug product development, Alan has first-hand knowledge of the steps necessary to help new drug products reach the clinical stage. During his time in industry, Alan developed drugs for delivery to the lungs. His experience in this field has led to a comprehensive understanding of the steps necessary for the formulation, characterization, efficacy testing and safety testing of inhaled drug products.

STAFF

Dr. Donna Kidwell received her doctorate at the Ecole de Management in Grenoble, France, and her Master’s in Science and Technology Commercialization at The University of Texas at Austin. She led the development of The Innovation Readiness Series™, an online course developed to help global innovators. Her research interests include innovation and commercialization. She has worked globally to encourage economic development through science and innovations. Prior to her work with UT Austin, Donna was a software consultant, and developed custom database applications and eLearning environments for companies such as Exxon, Agilent, and Keller Williams Realty International. She is passionate about creating action based online systems to educate and help others achieve their goals.

1. Course Number
   UT.4.01x
2. Classes Start
   Sep 16, 2013
3. Classes End
   Nov 8, 2013
4. Prerequisites
   None

Register For  UT.4.01x: Take Your Medicine - The Impact of Drug Development

Posted by Editorial Team on 12:30 PM in Edx, Medicine, UTAustinX